Drug Pipeline Progress: Positive clinical trial results or regulatory approvals for PharmaZone's drug candidates can significantly increase stock price.

Financial Performance: Revenue growth, profitability, and strong cash flow attract investors and drive the price upward. Losses can have the opposite effect.

Market Sentiment: Overall investor confidence in the pharmaceutical industry and the broader stock market influences PHRZF's valuation.

Competition: Competitor's advancements or new drug approvals can negatively impact PharmaZone's market share and stock price.

Regulatory Changes: New laws or regulations affecting drug pricing, approval processes, or intellectual property rights can have both positive or negative impacts.

Management Decisions: Strategic decisions made by PharmaZone's management, such as acquisitions, partnerships, or restructuring efforts, can affect investor perception.

Economic Conditions: General economic factors like interest rates, inflation, and GDP growth can indirectly impact the pharmaceutical industry and its stocks.

Global Events: Political instability or global health crises can disrupt supply chains, impact demand for drugs, and ultimately affect the stock price.